Point-of-care-testing (POCT) should be strategically utilized only in scenarios where it significantly influences immediate treatment decisions and offers a distinct advantage over traditional laboratory testing. Unlike laboratory-based tests, POCT may lead to more frequent false results potentially causing misdiagnoses, incorrect treatment decisions, and unnecessary additional testing or procedures contributing to further increased costs and medical waste. POCT’s reliance on single use, fossil-derived plastics, not only generates considerable waste but also poses environmental and health risks through potential toxic emissions from incineration.
Sources:
Canada’s Drug Agency: Evidence on Point-of-Care Testing. CADTH.
Lingervelder D, Koffijberg H, Kusters R, et al. Health Economic Evidence of Point-of-Care Testing: A Systematic Review. Pharmacoecon Open. 2021 Jun;5(2):157-173. PMID: 33405188.
Ongaro AE, Ndlovu Z, Sollier E, Otieno C, Ondoa P, Street A, Kersaudy-Kerhoas M. Engineering a sustainable future for point-of-care diagnostics and single-use microfluidic devices. Lab Chip. 2022 Aug 23;22(17):3122-3137. PMID: 35899603.
Ortiz DA, Loeffelholz MJ. Practical Challenges of Point-of-Care Testing. Clin Lab Med. 2023 Jun;43(2):155-165. PMID: 37169439.